158 related articles for article (PubMed ID: 7994023)
1. Identification of potential hot spots in the carboxy-terminal part of the Epstein-Barr virus (EBV) BNLF-1 gene in both malignant and benign EBV-associated diseases: high frequency of a 30-bp deletion in Malaysian and Danish peripheral T-cell lymphomas.
Sandvej K; Peh SC; Andresen BS; Pallesen G
Blood; 1994 Dec; 84(12):4053-60. PubMed ID: 7994023
[TBL] [Abstract][Full Text] [Related]
2. Epstein-Barr virus latent membrane protein-1 oncogene deletions: correlations with malignancy in Epstein-Barr virus--associated lymphoproliferative disorders and malignant lymphomas.
Kingma DW; Weiss WB; Jaffe ES; Kumar S; Frekko K; Raffeld M
Blood; 1996 Jul; 88(1):242-51. PubMed ID: 8704180
[TBL] [Abstract][Full Text] [Related]
3. Common Epstein-Barr virus (EBV) type-1 variant strains in both malignant and benign EBV-associated disorders.
Schuster V; Ott G; Seidenspinner S; Kreth HW
Blood; 1996 Feb; 87(4):1579-85. PubMed ID: 8608250
[TBL] [Abstract][Full Text] [Related]
4. Significance of the detection of Epstein-Barr virus DNA in lymph nodes in patients with Hodgkin's disease.
Knecht H; Joske DJ; Bachmann E; Sahli R; Odermatt BF
Leuk Lymphoma; 1992 Nov; 8(4-5):319-25. PubMed ID: 1337849
[TBL] [Abstract][Full Text] [Related]
5. A deletion mutant of the LMP1 oncogene of Epstein-Barr virus is associated with evolution of angioimmunoblastic lymphadenopathy into B immunoblastic lymphoma.
Knecht H; Martius F; Bachmann E; Hoffman T; Zimmermann DR; Rothenberger S; Sandvej K; Wegmann W; Hurwitz N; Odermatt BF
Leukemia; 1995 Mar; 9(3):458-65. PubMed ID: 7885044
[TBL] [Abstract][Full Text] [Related]
6. High prevalence of a 30-base pair deletion and single-base mutations within the carboxy terminal end of the LMP-1 oncogene of Epstein-Barr virus in the Japanese population.
Itakura O; Yamada S; Narita M; Kikuta H
Oncogene; 1996 Oct; 13(7):1549-53. PubMed ID: 8875994
[TBL] [Abstract][Full Text] [Related]
7. Epstein-Barr virus and Hodgkin's disease: transcriptional analysis of virus latency in the malignant cells.
Deacon EM; Pallesen G; Niedobitek G; Crocker J; Brooks L; Rickinson AB; Young LS
J Exp Med; 1993 Feb; 177(2):339-49. PubMed ID: 8381153
[TBL] [Abstract][Full Text] [Related]
8. [Sequence analysis of the carboxy terminal of the Epstein-Barr virus LMP-1 oncogene in Epstein-Barr virus associated disorders].
Itakura O; Kikuta H
Nihon Rinsho; 1997 Feb; 55(2):467-72. PubMed ID: 9046842
[TBL] [Abstract][Full Text] [Related]
9. Characteristics of Epstein-Barr virus isolated from the malignant lymphomas in Korea.
Kim I; Park ER; Park SH; Lin Z; Kim YS
J Med Virol; 2002 May; 67(1):59-66. PubMed ID: 11920819
[TBL] [Abstract][Full Text] [Related]
10. Clonality, expression and methylation patterns of the Epstein-Barr virus genomes in lethal midline granulomas classified as peripheral angiocentric T cell lymphomas.
Minarovits J; Hu LF; Imai S; Harabuchi Y; Kataura A; Minarovits-Kormuta S; Osato T; Klein G
J Gen Virol; 1994 Jan; 75 ( Pt 1)():77-84. PubMed ID: 8113742
[TBL] [Abstract][Full Text] [Related]
11. Mutational hot spots within the carboxy terminal region of the LMP1 oncogene of Epstein-Barr virus are frequent in lymphoproliferative disorders.
Knecht H; Bachmann E; Brousset P; Rothenberger S; Einsele H; Lestou VS; Delsol G; Bachmann F; Ambros PF; Odermatt BF
Oncogene; 1995 Feb; 10(3):523-8. PubMed ID: 7845677
[TBL] [Abstract][Full Text] [Related]
12. Deletion of Epstein-Barr virus latent membrane protein 1 gene in United States and Brazilian Hodgkin's disease and reactive lymphoid tissue: high frequency of a 30-bp deletion.
Hayashi K; Chen WG; Chen YY; Bacchi MM; Bacchi CE; Alvarenga M; Abreu ES; Chang KL; Weiss LM
Hum Pathol; 1997 Dec; 28(12):1408-14. PubMed ID: 9416698
[TBL] [Abstract][Full Text] [Related]
13. Molecular analysis of latent membrane protein 1 in patients with Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in Japan.
Tabata YHibi S; Teramura T; Kuriyama K; Yagi T; Todo S; Sawada T; Imashuku S
Leuk Lymphoma; 2000 Jul; 38(3-4):373-80. PubMed ID: 10830744
[TBL] [Abstract][Full Text] [Related]
14. High frequency of Epstein Barr virus latent membrane protein-1 30 bp deletion in a series of pediatric malignancies in Argentina.
Chabay P; De Matteo E; Merediz A; Preciado MV
Arch Virol; 2004 Aug; 149(8):1515-26. PubMed ID: 15290377
[TBL] [Abstract][Full Text] [Related]
15. Oligonucleotides for polymerase chain reaction amplification and hybridization detection of Epstein-Barr virus DNA in clinical specimens.
Ambinder RF; Lambe BC; Mann RB; Hayward SD; Zehnbauer BA; Burns WS; Charache P
Mol Cell Probes; 1990 Oct; 4(5):397-407. PubMed ID: 2177846
[TBL] [Abstract][Full Text] [Related]
16. [Internal deletions of the latent membrane protein oncogenes of Epstein-Barr virus in Hodgkin's disease are almost identical with those of Asiatic nasopharyngeal carcinoma].
Odermatt BF; Heitz PU; Bachmann E; Brousset P; Sandvej K; Knecht H
Verh Dtsch Ges Pathol; 1994; 78():324-8. PubMed ID: 7534006
[TBL] [Abstract][Full Text] [Related]
17. Epstein-Barr virus strains with latent membrane protein-1 deletions: prevalence in the Italian population and high association with human immunodeficiency virus-related Hodgkin's disease.
Dolcetti R; Zancai P; De Re V; Gloghini A; Bigoni B; Pivetta B; De Vita S; Carbone A; Boiocchi M
Blood; 1997 Mar; 89(5):1723-31. PubMed ID: 9057656
[TBL] [Abstract][Full Text] [Related]
18. High prevalence of a 30-base pair deletion in the Epstein-Barr virus (EBV) latent membrane protein 1 gene and of strain type B EBV in Mexican classical Hodgkin's disease and reactive lymphoid tissue.
Dirnhofer S; Angeles-Angeles A; Ortiz-Hidalgo C; Reyes E; Gredler E; Krugmann J; Fend F; Quintanilla-Martinez L
Hum Pathol; 1999 Jul; 30(7):781-7. PubMed ID: 10414496
[TBL] [Abstract][Full Text] [Related]
19. Isolation and analysis of two strongly transforming isoforms of the Epstein-Barr-Virus(EBV)-encoded latent membrane protein-1 (LMP1) from a single Hodgkin's lymphoma.
Mehl AM; Fischer N; Rowe M; Hartmann F; Daus H; Trümper L; Pfreundschuh M; Müller-Lantzsch N; Grässer FA
Int J Cancer; 1998 Apr; 76(2):194-200. PubMed ID: 9537580
[TBL] [Abstract][Full Text] [Related]
20. Analysis of the Epstein-Barr virus (EBV) latent membrane protein 1 (LMP-1) gene and promoter in Hodgkin's disease isolates: selection against EBV variants with mutations in the LMP-1 promoter ATF-1/CREB-1 binding site.
Sandvej K; Andresen BS; Zhou XG; Gregersen N; Hamilton-Dutoit S
Mol Pathol; 2000 Oct; 53(5):280-8. PubMed ID: 11091852
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
